MAE BURTON: Open Payments
NPI 1407927155 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,139 in 224 payments from 25 companies in 2025. Trend: 2023 $4,763 · 2024 $4,158 · 2025 $5,139
Food & beverage: $5,139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $592 |
| Amgen Inc. | 38 | $577 |
| UCB, Inc. | 26 | $573 |
| Janssen Biotech, Inc. | 18 | $448 |
| GlaxoSmithKline, LLC. | 10 | $412 |
| Mallinckrodt Hospital Products Inc. | 15 | $375 |
| E.R. Squibb & Sons, L.L.C. | 9 | $332 |
| AstraZeneca Pharmaceuticals LP | 9 | $279 |
| ANI Pharmaceuticals, Inc. | 10 | $235 |
| Lilly USA, LLC | 13 | $212 |
Products named: Bimzelx, TREMFYA, RINVOQ, BENLYSTA, ACTHAR, ORENCIA, SAPHNELO, PURIFIED CORTROPHIN GEL.
Industry payments across SC — which companies pay providers there.
